Xiaojun Xu Selected Research

Xiaojun Xu Research Topics

Disease

26	Neoplasms (Cancer) 01/2022 - 03/2009
16	Parkinson Disease (Parkinson's Disease) 06/2022 - 11/2014
9	Alzheimer Disease (Alzheimer's Disease) 05/2021 - 01/2015
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2021 - 01/2015
6	Cognitive Dysfunction 01/2021 - 10/2016
6	Insulin Resistance 01/2021 - 08/2015
6	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2018
5	Hyperlipidemias (Hyperlipidemia) 01/2022 - 12/2016
5	Leukemia 01/2022 - 07/2011
5	Infections 11/2018 - 04/2004
5	Inflammation (Inflammations) 08/2018 - 01/2013
5	Hepatocellular Carcinoma (Hepatoma) 11/2017 - 01/2012
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2022 - 04/2011
4	Type 2 Diabetes Mellitus (MODY) 11/2021 - 12/2015
4	Fatty Liver 01/2021 - 12/2015
3	Fever (Fevers) 09/2022 - 09/2014
3	Disease Progression 02/2022 - 01/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
3	Dementia (Dementias) 01/2022 - 01/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 03/2014
3	Obesity 01/2021 - 12/2016
3	Genomic Instability 09/2020 - 01/2020
3	Pain (Aches) 01/2019 - 04/2011
3	Neoplasm Metastasis (Metastasis) 01/2018 - 02/2013
3	Bacterial Infections (Bacterial Infection) 09/2014 - 07/2011
2	Tremor (Tremors) 06/2022 - 01/2017
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 01/2017
2	Lymphoid Leukemia 01/2022 - 01/2022
2	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2014
2	Hypoxia (Hypoxemia) 12/2021 - 07/2016
2	Non-alcoholic Fatty Liver Disease 07/2021 - 01/2019
2	Dyslipidemias (Dyslipidemia) 01/2021 - 08/2017
2	Osteoporosis 01/2020 - 08/2017
2	Alcoholic Fatty Liver 03/2019 - 02/2019
2	Arthritis (Polyarthritis) 01/2019 - 07/2015
2	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 08/2018 - 08/2015
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 08/2018 - 01/2013
2	Stroke (Strokes) 08/2018 - 01/2016
2	Diabetic Nephropathies (Diabetic Nephropathy) 08/2018 - 11/2017
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017 - 12/2015
2	Carcinogenesis 03/2014 - 03/2014
2	Emphysema 01/2013 - 04/2012
2	Neutropenia 01/2012 - 07/2011
2	Sepsis (Septicemia) 07/2011 - 10/2008
1	Wounds and Injuries (Trauma) 11/2022
1	Vomiting 09/2022
1	Pancreatitis 09/2022
1	Abdominal Pain (Pain, Abdominal) 09/2022
1	Nausea 09/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2022
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2022

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2016
8	Pharmaceutical PreparationsIBA 01/2022 - 01/2015
8	IronIBA 10/2021 - 03/2008
7	Biological ProductsIBA 01/2022 - 01/2013
7	Proteins (Proteins, Gene)FDA Link 08/2021 - 03/2009
6	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 08/2015
6	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2008
5	CytokinesIBA 05/2020 - 04/2004
4	Dopamine (Intropin)FDA LinkGeneric 06/2022 - 11/2014
4	Interleukin-10 (Interleukin 10)IBA 01/2022 - 10/2008
4	Amyloid (Amyloid Fibrils)IBA 05/2021 - 12/2016
4	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2016
3	Levodopa (L Dopa)FDA LinkGeneric 06/2022 - 01/2021
3	ApolipoproteinsIBA 01/2021 - 01/2016
2	Cholinergic Agents (Cholinergics)IBA 06/2022 - 01/2021
2	berbineIBA 01/2022 - 10/2021
2	eltrombopag FDA Link 01/2022 - 01/2017
2	Inosine Triphosphate (ITP)IBA 01/2022 - 01/2017
2	InterleukinsIBA 01/2022 - 10/2008
2	Arsenic Trioxide (Trisenox)FDA Link 01/2022 - 01/2015
2	Oxygen (Dioxygen)IBA 12/2021 - 03/2009
2	Gemcitabine FDA Link 08/2021 - 03/2014
2	LipidsIBA 07/2021 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 08/2017
2	triptolideIBA 09/2020 - 01/2013
2	tocilizumab (atlizumab)FDA Link 05/2020 - 01/2018
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2019 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 07/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2015
2	CollagenIBA 01/2019 - 07/2015
2	CreatinineIBA 11/2018 - 08/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2015
2	SurvivinIBA 11/2017 - 03/2014
2	anhydroicaritinIBA 08/2017 - 12/2016
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2017 - 07/2015
2	Messenger RNA (mRNA)IBA 07/2016 - 02/2012
2	Ion Channels (Ion Channel)IBA 07/2015 - 04/2011
2	shogaolIBA 03/2014 - 01/2012
2	Pancreatic Elastase (Elastase)IBA 01/2013 - 04/2012
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2012 - 07/2011
2	Interleukin-4 (Interleukin 4)IBA 01/2012 - 10/2008
1	2-(N-cyclohexylamino)ethanesulfonic acid (CHES)IBA 11/2022
1	antiarrhythmic peptide (AAP)IBA 09/2022
1	Asparaginase (Elspar)FDA Link 09/2022
1	venetoclaxIBA 02/2022

Therapy/Procedure

13	Therapeutics 08/2021 - 03/2009
9	Drug Therapy (Chemotherapy) 09/2022 - 01/2012
2	Hematopoietic Stem Cell Transplantation 01/2017 - 01/2015
1	Transplantation 01/2022